Kawasaki disease classification

	Kawasaki disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Kawasaki disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Guidelines for Management
Case Studies
Case #1
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Kawasaki disease classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Kawasaki disease classification
CDC on Kawasaki disease classification
Kawasaki disease classification in the news
Blogs on Kawasaki disease classification
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Kawasaki disease classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]

Overview[edit | edit source]

Patients whose illness does not meet the diagnostic criteria of Kawasaki disease, but who have fever and coronary artery abnormalities, are classified as atypical or incomplete Kawasaki disease. For patients of atypical or incomplete Kawasaki disease, an evidence of coronary abnormalities or CAAs must be shown on the echocardiogram.

Patients whose illness does not meet the diagnostic criteria of Kawasaki disease, but who have fever and coronary artery abnormalities, are classified as:^[1]
- Atypical Kawasaki disease
- Incomplete Kawasaki disease
For the patients of atypical or incomplete Kawasaki disease, an evidence of coronary abnormalities or CAA’s must be shown on the echocardiogram.^[2]

↑ Sánchez-Manubens J, Bou R, Anton J (2014). "Diagnosis and classification of Kawasaki disease". J. Autoimmun. 48-49: 113–7. doi:10.1016/j.jaut.2014.01.010. PMID 24485156.
↑ Newburger, J. W.; Takahashi, M.; Gerber, M. A.; Gewitz, M. H.; Tani, L. Y.; Burns, J. C.; Shulman, S. T.; Bolger, A. F.; Ferrieri, P.; Baltimore, R. S.; Wilson, W. R.; Baddour, L. M.; Levison, M. E.; Pallasch, T. J.; Falace, D. A.; Taubert, K. A. (2004). "Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association". PEDIATRICS. 114 (6): 1708–1733. doi:10.1542/peds.2004-2182. ISSN 0031-4005.